If CytoDyn can’t get Leronlimab approved, these shareholders have a bold plan to tap into big pharma

News Godzilla
Copyright 2021 novcog.com news network We rock so you don''t have to.


If CytoDyn can’t get Leronlimab approved, these shareholders have a bold plan to tap into big pharma If CytoDyn can’t get Leronlimab approved, these shareholders have a bold plan to tap into big pharma

If CytoDyn’s leadership cannot get their lead treatment approved, a group of very optimistic investors would like to give it a try. After weeks of public power struggles (PDF) at the biotech company in Vancouver, Washington, a group of shareholders presented a strategic plan to get Leronlimab approved in a cancer indication. To quickly sum […] The post If CytoDyn can’t get Leronlimab approved,..
previous post